THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE again shows bold initiative to attract the top names to create a critical mass. This will become doubly significant as Japan’s strategic initiative to prioritize pluripotent stem cell therapies kicks into action, and gives this traditionally underfunded and undervalued sector the horsepower that it needs. It will become the third leg of medicine’s stool — drugs, biologicals and now stem cells.
http://lnkd.in/BDqXNE
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022